| Title | Cardiovascular Therapeutics |
| Abbreviation | Cardiovasc. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2) |
| h-index | 59 |
| Overall Rank/Ranking | 6418 |
| SCImago Journal Rank (SJR) | 0.831 |
| Impact Score | 3.64 |
| Publisher | John Wiley and Sons Inc |
| Country | United Kingdom |
| ISSN | 17555914, 17555922 |
| Best Quartile | Q2 |
| Coverage History | 2008-2025 |
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.
Cardiovascular Therapeutics is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2). It is published by John Wiley and Sons Inc. The overall rank of Cardiovascular Therapeutics is 6418. According to SCImago Journal Rank (SJR), this journal is ranked 0.831. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 59. The best quartile for this journal is Q2.
The ISSN of Cardiovascular Therapeutics journal is 17555914, 17555922. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cardiovascular Therapeutics is cited by a total of 486 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Cardiovascular Therapeutics is 3.64, which is computed in 2025 as per its definition. Cardiovascular Therapeutics IF is increased by a factor of 0.21 and approximate percentage change is 6.12% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Cardiovascular Therapeutics is 3.64. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 3.64 |
| 2023 | 3.43 |
| 2022 | 3.02 |
| 2021 | 3.18 |
| 2020 | 2.44 |
| 2019 | 2.42 |
| 2018 | 2.22 |
| 2017 | 2.31 |
| 2016 | 2.52 |
| 2015 | 2.50 |
| 2014 | 2.75 |
Cardiovascular Therapeutics has an h-index of 59. It means 59 articles of this journal have more than 59 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cardiovascular Therapeutics is 17555914, 17555922. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cardiovascular Therapeutics is 6418. According to SCImago Journal Rank (SJR), this journal is ranked 0.831. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.831 |
| 2023 | 0.769 |
| 2022 | 0.790 |
| 2021 | 0.725 |
| 2020 | 0.818 |
| 2019 | 0.839 |
| 2018 | 0.780 |
| 2017 | 1.075 |
| 2016 | 1.095 |
| 2015 | 1.259 |
| 2014 | 1.051 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 6418 |
| 2023 | 6596 |
| 2022 | 6076 |
| 2021 | 6552 |
| 2020 | 5854 |
| 2019 | 5573 |
| 2018 | 6070 |
| 2017 | 3953 |
| 2016 | 3842 |
| 2015 | 3166 |
| 2014 | 4032 |
Cardiovascular Therapeutics is published by John Wiley and Sons Inc. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2008-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cardiovascular Therapeutics is Cardiovasc. Ther.. This abbreviation ('Cardiovasc. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cardiovascular Therapeutics latest impact IF is 3.64. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.64 (2024) and 2.22 (2018), respectively, in the last 11 years. Moreover, its average IS is 2.77 in the previous 11 years.
The Cardiovascular Therapeutics has an SJR (SCImago Journal Rank) of 0.831, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.259 in 2015 and the lowest being 0.725 in 2021. Furthermore, the average SJR of the Cardiovascular Therapeutics over the previous 11-year period stands at 2.77.
The latest h-index of the Cardiovascular Therapeutics is 59.
The Cardiovascular Therapeutics is published by the John Wiley and Sons Inc, with its country of publication being the United Kingdom.
The Cardiovascular Therapeutics is currently ranked 6418 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 3166 in 2015 and its lowest position of 6596 in 2023.
The standard ISO4 abbreviation for the Cardiovascular Therapeutics is Cardiovasc. Ther..
Cardiovascular Therapeutics is classified as a journal that the John Wiley and Sons Inc publishes.
The Cardiovascular Therapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cardiovascular Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 17555914, 17555922.
The best quartile for the Cardiovascular Therapeutics is Q2 (2024).
The Cardiovascular Therapeutics coverage history can be summarized as follows: 2008-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Journal of Supply Chain Management | journal | 331 | Wiley-Blackwell | 119 | 9.76 |
| Howard Journal of Communications | journal | 14582 | Taylor and Francis Ltd. | 42 | 1.27 |
| Educational Measurement: Issues and Practice | journal | 6760 | Wiley-Blackwell Publishing Ltd | 68 | 1.54 |
| Proteomics - Clinical Applications | journal | 8540 | Wiley-VCH Verlag | 67 | 2.59 |
| East African journal of public health | journal | 19634 | East African Public Health Association | 23 | 0.00 |
| American Journal of Immunology (discontinued) | journal | 19764 | Science Publications | 12 | 1.56 |
| Plant Root | journal | 22043 | Japanese Society for Root Research | 14 | 0.20 |
| Innovations in Pharmaceutical Technology | trade journal | 26994 | Samedan Ltd | 9 | 0.00 |
| Acta Colombiana de Psicologia | journal | 20042 | Universidad Catolica de Colombia | 18 | 0.67 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 3.64 |
| 2023 | 3.43 |
| 2022 | 3.02 |
| 2021 | 3.18 |
| 2020 | 2.44 |
| 2019 | 2.42 |
| 2018 | 2.22 |
| 2017 | 2.31 |
| 2016 | 2.52 |
| 2015 | 2.50 |
| 2014 | 2.75 |
